
Lionheart Stimulus 240 Stimulator
The Lionheart Stimulus™ 240 Stimulator is a professional-grade 4-channel electrotherapy…
$21,995.00

BladderCell is a bioelectronic medicine company focused on bladder and urothelial regeneration. Using patented bioelectric signaling and advanced biologics, it aims to restore bladder function, improve muscle elasticity, and eliminate urinary incontinence without the need for invasive major surgery.
Discover our background, mission, and the world-class research driving our next-generation medical technology.
Treating incontinence via bladder regeneration. The BladderCell technology platform is the only one known with these patented or patent pending bioelectric signaling sequences. The original patent pending BladderCell device design has these primary components to its candidate therapy:
MicroImplant Stimulator for Improving Bladder Function via Bioelectric Controlled Protein Expressions. Only stimulator to control these protein expressions for these purposes:
BladderCell via a combination of patented bioelectric signaling sequences to control regenerative protein expressions is harnessing natural healing regenerative processes in developing combination devices and methods for voiding dysfunction, including decompensated bladder and overactive bladder.
The properly functioning urinary bladder is composed of a compliant muscular wall, effective neuromuscular connections, and a highly specialized urothelial layer. In dysfunction often all these key contributors to healthy normal bladder function are compromised in a deteriorated state. BladderCell is the only known therapy under development attempting to target ALL.
OF THE 25 MILLION ADULT AMERICANS SUFFERING FROM SOME FORM OF URINARY INCONTINENCE, 75-80% OF THOSE ARE WOMEN.
Want to learn more? Browse our clinical resources and scientific publications on our latest updates and insights.
Discover the science and innovation driving our advanced solutions, designed to deliver safe, effective, and transformative results.
BladderCell is the only firm working on developing treatments for all levels of bladder dysfunction—from mild leaks to severe chronic conditions. Our technology combines patented bioelectric signaling with regenerative biologics. BladderCell is developing three (3) platforms for treating incontinence via bladder regeneration.
For mild to moderate cases of bladder dysfunction.
For moderate to severe cases of bladder dysfunction.
For severe advanced cases of bladder dysfunction and total bladder regeneration.
Don’t see your question? Reach out and our clinical team will respond personally.
Bioelectric therapy for bladder regeneration focused on precise bioelectrical signaling sequences for controlling specific regenerative protein expressions for specific purposes which may include fully or partially…
Note – Current bioelectric portable palm-sized external at home use stimulator is limited to 6 bioelectric signaling sequences in each auto program run.
Bioelectric therapy combined with PRF (platelet rich fibrin) and regenerative fluid (may be amniotic fluid or selected exosomes).
Bioelectric therapy combined with muscle stem cells (immature myoblasts), heat shock treated MSCs, heat shock proteins, stromal fraction, selected growth factors such as klotho, SDF1, follistatin, PRF, amniotic fluid, exosomes, micro RNA gel, nutrient hydrogel, selected alkaloids, Wharton’s Jelly, oxygenated nanoparticles and bladder extracellular matrix.
Want to learn more? Browse our clinical resources and scientific publications on our comprehensive suite of targeted treatments.
This section details our strategic business framework and legal protections. It includes patents and roadmaps that safeguard our proprietary bioelectric signaling and ensure market exclusivity for our regenerative platform.
This group focuses on technical engineering and clinical parameters. It provides clinicians with specific data on device specifications, biological formulations, and protocols necessary for the effective application of our multi-tier therapy.
This evidentiary section presents clinical results from world-class institutions. These studies document successful patient outcomes in restoring bladder control and validate the life-changing impact of our targeted bioelectric medical interventions.
This group explains the advanced science of stem cells and tissue engineering. It explores global research on harnessing biological potential to rebuild damaged organ tissues and nerve pathways through our total regeneration approach.
Want to learn more? Browse our clinical resources and scientific publications on our latest updates and insights.
CAUTION Disclaimer and Warning
Products described on this web site are in early stage development and are not yet proven safe or effective in statistically significant controlled clinical studies. Any statement or phrases implying efficacy or safety in any form are considered modified by “intended to” or “designed to”. Investigational use only in countries where investigation is permitted by law and proper filings have been made and appropriate regulatory clearances have been granted. Any use of the product(s) must be in an authorized clinical study with institutional review board (ethics committee) approval and proper patient consent procedures followed. For other countries product is only available for laboratory investigation by credentialed institutions and investigators with proper clearances with a research agreement in place with a study sponsor. NOT AVAILABLE FOR SALE.
Leonhardt Ventures is registered as Leonhardt Vineyards LLC a State of California LLC since 2005 DBA Leonhardt Ventures DBA Filing Document No. 2013239458 Los Angeles County 11/20/13.
BladderCell offers the only regenerative therapies for mild, moderate, and severe bladder dysfunction. Our patented bioelectric signaling homes stem cells and restores muscle tissue, nerve connections, and elasticity to help you regain control without major surgery.